Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
31.18
-0.86 (-2.67%)
At close: Nov 12, 2025, 4:00 PM EST
31.10
-0.07 (-0.24%)
Pre-market: Nov 13, 2025, 8:19 AM EST
Legend Biotech Revenue
Legend Biotech had revenue of $272.33M in the quarter ending September 30, 2025, with 69.99% growth. This brings the company's revenue in the last twelve months to $909.05M, up 74.75% year-over-year. In the year 2024, Legend Biotech had annual revenue of $627.24M with 119.97% growth.
Revenue (ttm)
$909.05M
Revenue Growth
+74.75%
P/S Ratio
6.31
Revenue / Employee
$348,427
Employees
2,609
Market Cap
5.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 627.24M | 342.10M | 119.97% |
| Dec 31, 2023 | 285.14M | 168.14M | 143.70% |
| Dec 31, 2022 | 117.01M | 48.18M | 70.00% |
| Dec 31, 2021 | 68.83M | -6.17M | -8.23% |
| Dec 31, 2020 | 75.00M | 13.20M | 21.36% |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
LEGN News
- 19 hours ago - Legend Biotech Corporation (LEGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 15 days ago - Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results - GlobeNewsWire
- 4 weeks ago - US FDA adds boxed warning to J&J, Legend Biotech's cancer therapy - Reuters
- 5 weeks ago - My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
- 2 months ago - Legend Biotech Corporation (LEGN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - Legend Biotech Appoints Carlos Santos as Chief Financial Officer - GlobeNewsWire
- 3 months ago - Legend Biotech: Q2 Record Sales Undermined By Losses, Immature Pipeline - Rating Downgrade - Seeking Alpha